Researchers sought to determine the balance between the efficacy and toxicity when administering CAR T-cell therapy.
Results of a real-world study suggest that early death may be common among cancer patients taking immune checkpoint inhibitors.
Data suggest that brain tumors are the fifth most prevalent cancer type in the US, after female breast cancer, prostate cancer, colorectal cancer, and melanoma.
Cancer patients with type 2 diabetes may have worse survival outcomes on immune checkpoint inhibitor therapy, a new study suggests.
Researchers explored the effectiveness and safety of parenteral morphine, oxycodone, and hydromorphone in treating terminal dyspnea in patients with cancer.
Cancer patients who use telemedicine report better experiences than cancer patients treated in person, according to a new study.
An ultrasound technique allows for delivery of albumin-bound paclitaxel across the blood-brain barrier in patients with recurrent glioblastoma, a study suggests.
Higher levels of certain sex hormones are associated with an increased risk of some gastrointestinal cancers, a meta-analysis suggests.
Researchers sought to determine the impact of extreme poverty on the risk of relapse in pediatric patients with ALL.
Researchers investigated whether body roundness index is associated with a person’s risk of developing colorectal cancer.
US counties with food deserts or food swamps tend to have higher rates of death from obesity-related cancers, a study suggests.
Researchers evaluated the efficacy and safety of disulfiram and copper as add-on alkylating chemotherapy in patients with recurrent glioblastoma.
Researchers say they have identified 4 subtypes of prostate cancer with distinct biological and clinical features, and these subtypes may respond differently to treatment.
A recent study found a racial disparity in the use of guideline-concordant treatment for metastatic prostate cancer.
Breast cancer patients who receive a peritumoral injection of lidocaine immediately before surgery have better survival outcomes, a study suggests.
The withdrawn approvals of ibrutinib for relapsed/refractory MCL and MZL are likely to have a limited impact on patients, experts say.
Clinician-led discussion of PSA testing advantages was associated with overscreening among older men.
From 15 to 40 years after diagnosis, pediatric cancer survivors have a roughly 4-fold higher risk of death than the general population, a study suggests.
Researchers assessed the burden of anal human papillomavirus disease among patients with inflammatory bowel diseases.
Researchers compared several traditional Chinese medicine modalities to determine which may benefit patients with cancer who experience sleep disturbance.